剂量检测设计中的当前问题:对美国食品和药物管理局瘤中心卓越项目Optimus的回应
Peter F Thall1, Elizabeth Garrett-Mayer2, Nolan A Wages3
1Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Clinical trials (London, England)
|April 4, 2024
概括
传统的选择癌症药物剂量的方法是不够的. 项目Optimus和创新的临床试验设计旨在改善针对性药物和免疫疗法的剂量优化和选择.
科学领域:
- 在瘤学瘤学.
- 临床试验 临床试验
- 药物开发 药物开发
背景情况:
- 传统的I期临床试验设计不足以确定新的癌症疗法的最佳剂量.
- 这种不足影响了细胞毒剂,放射治疗,向药物和免疫疗法.
- 美国食品和药物管理局的瘤学卓越中心启动了Optimus项目,以改革瘤学药物开发中的剂量优化和选择.
研究的目的:
- 解决瘤学中常规剂量确定方法的局限性.
- 引入创新的设计,以优化药物开发中的剂量和时间表选择.
- 告知临床试验人员关于由Optimus项目推动的进展.
主要方法:
- 综述了剂量优化和选择方法的最新进展.
- 讨论监管倡议,包括美国FDA的Project Optimus项目.
- 在附带的文章中介绍的创新设计的摘要.
主要成果:
- 传统的I期设计不足以可靠地确定剂量.
- 项目Optimus正在推动瘤药物开发范式的改革.
- 创新设计为剂量优化提供了改进的方法.
结论:
- 迫切需要在瘤学中超越传统的I期设计.
- 监管支持,如 Project Optimus,鼓励采用更好的剂量优化策略.
- 本专题号强调了指导未来临床试验设计的关键进展.
更多相关视频
相关概念视频
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K


